Phase I to Test a New Pneumococcal Vaccine

Summary

To obtain first-in-human data on a new candidate vaccine against Streptococcus pneumoniae in healthy adult and elderly volunteers. The study aims to assess the safety and immunogenicity of a bioconjugate investigational vaccine compared to the control group (Pneumovax23).

Timeline

Start

2017-09-07

Primary completion

2018-09-12

Completion

2018-09-12

Drugs

Indications